帕金森病患者[11C]PBR28 PET未显示TSPO结合升高尽管多巴胺转运体结合降低
研究用[11C]PBR28 PET定量评估16例帕金森病患者与16名对照者的脑TSPO结合,并用[18F]FE-PE2I PET评估患者多巴胺转运体结合。结果显示TSPO基因型对[11C]PBR28脑结合有强主效应,但诊断组主效应及组×基因型交互作用均无统计学显著性;患者纹状体DAT结合明显降低,但[11C]PBR28与[18F]FE-PE2I结合参数间无相关性。结论不支持PD脑TSPO结合升高或TSPO结合与多巴胺能病理相关的假说。
要点
- TSPO基因型对[11C]PBR28脑结合有强主效应,诊断组主效应无统计学显著性。
- PD患者纹状体DAT结合明显降低,但TSPO与DAT结合参数间无相关性。
- 结果不支持PD脑TSPO结合升高或与多巴胺能病理相关的假说。
核心结论
- 研究结果不支持帕金森病脑TSPO结合升高或TSPO结合与多巴胺能病理相关的假说。
研究设计与样本
- 使用[11C]PBR28 PET定量评估16名对照者和16例PD患者的脑TSPO结合。
- PD患者另接受[18F]FE-PE2I PET以评估多巴胺转运体结合。
- 根据TSPO rs6971基因型分析,16名受试者(8名对照者和8例PD患者)为高亲和力结合者,其余为混合亲和力结合者。
主要发现
- 双因素方差分析显示TSPO基因型对[11C]PBR28脑结合有强主效应。
- 诊断组主效应及组×基因型交互作用在任何分析脑区均无统计学显著性。
- PD患者[18F]FE-PE2I PET显示纹状体DAT结合明显降低。
- [11C]PBR28与[18F]FE-PE2I的结合参数间未发现相关性。
关键数值与推荐
- [11C]PBR28总分布容积在纹状体、边缘皮质和丘脑定量。
- [18F]FE-PE2I结合潜力在纹状体区域定量。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To examine the hypothesis that cerebral binding to the 18 kDa translocator protein (TSPO), a marker of microglia activation, is elevated in Parkinson's disease (PD), and to assess the relationship between brain TSPO binding and dopaminergic pathology in PD. METHODS: The radioligand [11C]PBR28 was used for quantitative assessment of brain TSPO in 16 control subjects and 16 PD patients. To analyse the relationship between dopaminergic pathology and brain TSPO binding, PET studies of the dopamine transporter (DAT) were undertaken in PD patients using the DAT radioligand [18F]FE-PE2I. The total distribution volume of [11C]PBR28 was quantified in nigrostriatal regions, limbic cortices and thalamus, and the binding potential of [18F]FE-PE2I was quantified in nigrostriatal regions. RESULTS: Based on genotype analysis of the TSPO rs6971 polymorphism, 16 subjects (8 control subjects and 8 PD patients) were identified as high-affinity binders, and the remaining subjects were identified as mixed-affinity binders. A two-way ANOVA showed a strong main effect of TSPO genotype on the cerebral binding of [11C]PBR28, whereas no statistically significant main effect of diagnostic group, or a group by genotype interaction was found for any of the regions analysed. [18F]FE-PE2I PET studies in patients indicated a marked reduction in nigrostriatal binding to DAT. However, no correlations between the binding parameters were found for [11C]PBR28 and [18F]FE-PE2I. CONCLUSION: The findings do not support the hypothesis of elevated cerebral TSPO binding or a relationship between TSPO binding and dopaminergic pathology in PD.
引用
- Varnäs K, Cselényi Z, Jucaite A, et al. PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding. Eur J Nucl Med Mol Imaging. 2018. PMID: 30270409. doi:10.1007/s00259-018-4161-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。